synthetic biologics - investors

synthetic DNA-based therapeutics and innovative medicines for serious illnesses

home about us synthetic biologics funded clinical programs investors press releases events sec filings interactive stock chart historical stock price analyst coverage corporate governance investor alerts contact us

investors

recent press releases

May 15, 2012

Synthetic Biologics Reports First Quarter 2012 Financial Results

May 14, 2012

Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs

May 11, 2012

Synthetic Biologics Appoints Jeffrey J. Kraws as Independent Chairman

events

"SYN IR" Mobile iPhone App

Thursday, April 26, 2012

Price Data

Print	Email

forward-looking statements

© Synthetic Biologics, Inc. 2012